Press-release for stocks related to expected for glaxf

| 2.88% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $140.3 -4.19% 1.5K

| 3.12% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -2.2% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -8.72% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 4.53% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 1.75% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -7.28% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.84 -5.65% -5.99% 310K

| 1.36% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 5.95% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -13.23% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K

| -16.3% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K

| 4.67% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| -18.36% | O: -3.53% H: 3.49% C: 3.4%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -8.89% | O: -0.59% H: 0.49% C: 0.41%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 4.61% | O: 0.26% H: 0.13% C: -0.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 2.37% | O: 0.19% H: 0.46% C: 0.43%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -7.17% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published: 2024-01-22 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| -1.24% | O: -2.34% H: 0.43% C: 0.43%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -8.29% | O: -1.11% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 3.36% | O: -0.76% H: 0.38% C: 0.13%
BMY | $48.86 -0.27% -0.02% 16M

| -1.43% | O: 0.22% H: 1.49% C: 0.89%
expected million reach infection treatment global study market

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 10.28% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| 5.19% | O: 0.94% H: 2.55% C: 2.55%
NVSEF | News | $96.0 6.88% 52K

| 5.59% | O: 2.52% H: 0.04% C: 0.04%
NVO | News | $126.16 -1.93% -0.23% 3.1M

| 30.64% | O: 0.87% H: 0.73% C: 0.28%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 5.1% | O: 0.16% H: 0.7% C: 0.57%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 14.45% | O: -4.06% H: 1.9% C: 0.96%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 28.84% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 2.3% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

Global Paronychia Treatment Market Size Expected to Grow by USD 933.78 Million By 2032, With 7.2% CAGR Rise: Polaris Market Research
Published: 2023-10-13 (Crawled : 14:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 8.35% | O: -1.42% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 0.49% | O: -0.55% H: 0.69% C: -0.09%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -4.63% | O: 0.64% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 10.4% | O: -0.3% H: 0.72% C: -0.6%
expected treatment research global market

Drug Delivery Technology Market is expected to reach US$ 143.5 billion by 2033 | Future Market Insights, Inc.
Published: 2023-10-09 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 9.73% | O: 0.41% H: 3.94% C: 3.94%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 1.25% | O: 0.01% H: 0.47% C: 0.45%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 11.49% | O: 0.82% H: 0.51% C: 0.41%
drug expected reach technology market

Global Diet Pills Market Research Report 2023: Market is Expected to Reach $ 2.47 Billion in 2027 - Focus on Xenical, Qsymia, Saxenda, Diethylpropion, Liraglutide, and Phentermine
Published: 2023-10-05 (Crawled : 10:00) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M

| 41.69% | O: -0.08% H: 1.44% C: 1.15%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 13.25% | O: -0.39% H: 0.72% C: 0.61%
report expected reach research global market

Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 9.28% | O: -1.1% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 12.66% | O: -0.91% H: 0.56% C: -0.5%
MRNA | News S | $108.82 0.86% 0.85% 3.4M

| -9.6% | O: 0.03% H: 0.37% C: 0.18%
DVAX | $11.42 -2.89% -2.98% 1.3M

| -11.61% | O: 0.08% H: 1.31% C: 0.77%
vaccine expected cancer global

Global Smart Food Market Report: Sector is Expected to Reach $1.1 Billion by 2031 at a CAGR of 9.1%
Published: 2023-05-11 (Crawled : 01:00) - prnewswire.com
SXT | $70.03 0.2% 0.0% 1.3M

Distribution Services

| -5.76% | O: -0.87% H: 1.32% C: 1.18%
K S | $58.75 1.05% 0.0% 2.3M

| -16.73% | O: 0.21% H: 0.07% C: 0.0%
INGR G | $115.1 0.67% 0.0% 190K

Process Industries

| 4.7% | O: -0.35% H: 0.28% C: 0.08%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 11.85% | O: -0.88% H: 0.25% C: 0.19%
BCPC | News | $140.585 -3.09% -3.19% 110K

Process Industries

| 12.35% | O: -0.86% H: 1.35% C: 0.81%
expected food reach global smart market

Global Active Pharmaceutical Ingredients Market Report 2023: Sector is Expected to Reach $386.2 Billion by 2032 at a CAGR of 6.4%
Published: 2023-05-04 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 7.68% | O: 0.05% H: 2.53% C: 1.39%
SNYNF | News | $94.25 -2.18% 480

| -12.56% | O: 2.74% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 11.3% | O: -0.63% H: 1.56% C: 1.37%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 13.87% | O: 0.8% H: 0.57% C: -0.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -14.66% | O: 0.81% H: 0.0% C: 0.0%
active report expected reach global market

The Worldwide Manual Toothbrush Industry is Expected to Reach $8.1 Billion by 2028
Published: 2023-01-17 (Crawled : 13:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 13.98% | O: -0.95% H: 3.65% C: 3.19%
UNLYF | $47.8536 1.3% 3.1K

| -4.22% | O: 1.38% H: 0.0% C: 0.0%
UL | $48.07 0.19% 1.42% 3M

| -6.55% | O: -0.68% H: 0.53% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 15.49% | O: 0.31% H: 0.62% C: 0.2%
expected

Mersana Therapeutics Provides Business Update and Announces Strategic Objectives and Expected Milestones
Published: 2023-01-06 (Crawled : 12:20) - globenewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 18.5% | O: -0.44% H: 1.85% C: 1.72%
MRSN | $2.89 -9.97% -11.07% 3.2M

| -45.35% | O: 1.33% H: 5.9% C: 3.93%
expected therapeutics update

The Global Addison's Disease Therapeutics Market is expected to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period
Published: 2022-11-30 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 19.08% | O: -0.06% H: 0.06% C: -1.08%
NVSEF | News | $96.0 6.88% 52K

| 31.96% | O: 1.83% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 12.58% | O: 1.22% H: 1.37% C: 1.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 18.92% | O: 0.09% H: 0.58% C: 0.58%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| 1.8% | O: 0.12% H: 2.44% C: 2.33%
BIIB | $201.91 4.52% 4.32% 3.3M

| -30.69% | O: 5.1% H: 1.83% C: -0.36%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -3.18% | O: 0.2% H: 1.91% C: 1.36%
global disease expected therapeutics market

The Global Migraine Drugs Market is expected to grow by $1 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

| -95.92% | O: -1.63% H: 3.73% C: 3.63%
AZNCF | News | $140.3 -4.19% 1.5K

| 5.82% | O: 3.09% H: 0.0% C: -1.59%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 14.76% | O: 0.74% H: 0.89% C: 0.53%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 24.23% | O: 2.04% H: 0.06% C: -0.36%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 8.27% | O: 0.27% H: 2.08% C: 1.1%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| 2.91% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 5.4% | O: 1.02% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 9.42% | O: 0.68% H: 0.35% C: -0.12%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -4.97% | O: 0.63% H: 0.87% C: -0.32%
global expected migraine market

Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published: 2022-10-06 (Crawled : 14:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 30.29% | O: -2.53% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -40.46% | O: -0.82% H: 0.03% C: -1.53%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -10.07% | O: -0.3% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 34.36% | O: -1.25% H: 0.53% C: -0.1%
BMY | $48.86 -0.27% -0.02% 16M

| -31.62% | O: -0.92% H: 0.06% C: -0.78%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 17.58% | O: -1.63% H: 0.0% C: 0.0%
research expected market

Immunosuppressants Market Size to Grow by USD 6.69 billion with Expected YOY of 5.3% in 2022 - Technavio
Published: 2022-10-04 (Crawled : 04:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K

| -26.7% | O: 5.79% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| 23.42% | O: 8.97% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| -29.28% | O: 1.34% H: 1.11% C: 1.11%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 32.45% | O: 0.8% H: 4.78% C: 4.78%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 28.28% | O: 1.37% H: 1.04% C: 0.66%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 35.07% | O: 1.59% H: 0.93% C: -0.07%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 21.31% | O: 0.64% H: 2.52% C: 2.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 20.53% | O: 2.72% H: 0.0% C: 0.0%
expected market

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 31.63% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | News | $96.0 6.88% 52K

| 54.88% | O: 1.87% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 32.3% | O: -1.26% H: 0.7% C: -0.23%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 28.87% | O: 0.17% H: 1.1% C: 0.16%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 38.7% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.56 0.35% 0.0% 2M

| 14.59% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 16.04% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $176.0 -19.21% 50

| -3.96% | O: -0.61% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 28.15% | O: 1.63% H: 0.0% C: -0.48%
CSLLY | $90.71 3.3% 35K

| -1.15% | O: -0.43% H: 1.81% C: 1.44%
GLAXF | News | $19.54 -14.18% 2.6K

| 38.33% | O: 1.05% H: 4.0% C: 4.0%
AZNCF | News | $140.3 -4.19% 1.5K

| 27.09% | O: 2.35% H: 0.0% C: -0.68%
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| -27.82% | O: -1.91% H: 2.64% C: 1.94%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 42.57% | O: 1.12% H: 2.14% C: 1.66%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 24.36% | O: 0.83% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 33.73% | O: 0.04% H: 3.14% C: 2.68%
vaccine expected funding growth market

Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research
Published: 2022-09-13 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 23.29% | O: -4.5% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| 18.22% | O: 1.78% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

| 13.83% | O: -1.22% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 25.92% | O: -1.39% H: 0.31% C: -1.16%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 17.97% | O: -1.19% H: 0.98% C: -1.44%
XERS | $1.765 -0.84% -0.85% 710K

| -3.83% | O: -4.92% H: 5.17% C: 2.87%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| 12.78% | O: -0.97% H: 0.16% C: -0.98%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 15.3% | O: -2.2% H: 0.2% C: -2.32%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 14.89% | O: -0.25% H: 0.05% C: -4.29%
research global expected market

The Rise In Obesity Rates Is Expected To Drive The Weight Loss Supplement Market To $55 Billion By 2026
Published: 2022-08-23 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 15.68% | O: -1.69% H: 0.0% C: 0.0%
K S | $58.75 1.05% 0.0% 2.3M

| -22.31% | O: -0.11% H: 1.09% C: 0.86%
GSK | News | $40.86 -0.92% -0.15% 1.7M